Inflammation in coronary artery diseases.

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Pathophysiology

Background:

• Atherosclerosis is increasingly understood as an inflammatory disease.
• Inflammatory mechanisms are involved in all stages of atherogenesis, from early endothelial dysfunction to acute coronary events.
• An imbalance between pro-inflammatory and anti-inflammatory factors drives atherosclerotic progression.

Purpose of the Study:

• To review the pivotal role of inflammation in atherosclerosis.
• To highlight the link between inflammation and early atherogenesis events like endothelial dysfunction and lipoprotein retention.
• To discuss the relevance of inflammatory biomarkers in cardiovascular disease research and therapeutic development.

Main Methods:

• Literature review of evidence supporting the inflammatory nature of atherosclerosis.
• Discussion of the involvement of inflammatory mechanisms in various stages and subsets of coronary artery disease.
• Exploration of the significance of inflammatory biomarkers in understanding pathophysiology and guiding therapeutic strategies.

Main Results:

• Inflammation is central to atherogenesis, influencing endothelial dysfunction, fatty streak formation, and plaque vulnerability.
• Early events in atherosclerosis, including vascular endothelial dysfunction and lipoprotein retention, are linked to inflammation.
• Inflammation is implicated in diverse coronary artery disease subsets, such as silent myocardial ischemia and in-stent restenosis.

Conclusions:

• Inflammatory mechanisms are fundamental to the development and progression of atherosclerosis.
• Identifying inflammatory biomarkers and pathways is crucial for advancing cardiovascular disease research.
• Targeting inflammation holds promise for developing novel therapeutic strategies to prevent or reverse atherosclerotic diseases.